Lee Ainslie – ALNY history
- Issuer:
- ALNYLAM PHARMACEUTICALS INC
- Quarters tracked:
- 16 (Q2 2018 → Q3 2026)
- Current shares:
- 907
- Current value:
- $224K
- Peak shares:
- 4,236,016 (Q2 2019)
- Overall change:
- -100%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q3 2026 | 907 | $224K | $246.97 | +907 | +100% |
| Q4 2021 | SOLD | — | — | -3,983 | -100% |
| Q3 2021 | 3,983 | $752K | $188.80 | -288,700 | -99% |
| Q2 2021 | 292,683 | $49.62M | $169.52 | -503,551 | -63% |
| Q1 2021 | 796,234 | $112.42M | $141.19 | -188,268 | -19% |
| Q4 2020 | 984,502 | $127.96M | $129.97 | +17,041 | +2% |
| Q3 2020 | 967,461 | $140.86M | $145.60 | -146,147 | -13% |
| Q2 2020 | 1,113,608 | $164.94M | $148.11 | -226,097 | -17% |
| Q1 2020 | 1,339,705 | $145.83M | $108.85 | -921,192 | -41% |
| Q4 2019 | 2,260,897 | $260.39M | $115.17 | -961,916 | -30% |
| Q3 2019 | 3,222,813 | $259.18M | $80.42 | -1,013,203 | -24% |
| Q2 2019 | 4,236,016 | $307.37M | $72.56 | +1,025,629 | +32% |
| Q1 2019 | 3,210,387 | $300.01M | $93.45 | +406,436 | +14% |
| Q4 2018 | 2,803,951 | $204.44M | $72.91 | +1,291,887 | +85% |
| Q3 2018 | 1,512,064 | $132.34M | $87.52 | +830,710 | +122% |
| Q2 2018 | 681,354 | $67.11M | $98.49 | — | NEW |